Equities

Hunan Warrant Pharmaceutical Co Ltd

688799:SHH

Hunan Warrant Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)42.97
  • Today's Change1.68 / 4.07%
  • Shares traded1.63m
  • 1 Year change+6.36%
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024 08:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hunan Warrant Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of chemical raw materials, chemical pharmaceutical preparations and traditional Chinese medicine preparations. The Company's products include pharmaceutical preparations, raw materials and intermediates, plant extracts and food. Its products cover areas such as digestion, breathing, and anti-infection. The Company mainly conducts business within the domestic market.

  • Revenue in CNY (TTM)1.45bn
  • Net income in CNY222.11m
  • Incorporated2001
  • Employees1.16k
  • Location
    Hunan Warrant Pharmaceutical Co LtdBuilding C6-C7, Jinrui Lugu ScienceTechnology Park, No. 28 Lutian RoadCHANGSHA 410006ChinaCHN
  • Phone+86 73 185910599
  • Fax+86 73 185910568
  • Websitehttp://www.warrant.com.cn
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zhejiang Starry Pharmaceutical Co Ltd2.27bn46.95m3.82bn1.85k81.572.17--1.680.13680.13686.635.150.41791.985.091,231,642.000.87893.301.805.9723.8632.352.108.210.41211.440.640553.083.0419.78158.32-13.9410.39--
Chengdu Olymvax Biopharmaceuticals Inc500.05m-12.30m3.94bn471.00--4.39--7.87-0.0303-0.03031.232.210.33380.41971.081,061,669.00-1.223.17-1.704.6893.2993.00-3.647.441.92-3.900.25059.82-9.3845.40-33.94--56.47--
Tibet Weixinkang Medicine Co Ltd1.29bn248.69m3.94bn701.0015.852.75--3.060.57150.57152.963.300.711418.195.881,840,383.0013.718.2017.7811.1350.8150.2019.2811.533.10--0.004559.11-5.4312.1320.9423.85-5.6138.96
Hunan Warrant Pharmaceutical Co Ltd1.45bn222.11m4.03bn1.16k18.152.26--2.782.372.3715.4419.010.67131.508.931,246,491.009.3111.2111.2114.0564.0969.0013.8813.963.02--0.02528.0510.8418.5015.6019.0224.49--
Sinotherapeutics Inc368.86m76.25m4.13bn260.0054.113.44--11.180.16820.16820.81372.650.2753.085.831,418,710.005.69--6.09--51.77--20.67--9.09--0.00006--21.13---34.29------
Jiangsu Bioperfectus Technologies Co Ltd400.25m-314.32m4.21bn684.00--1.22--10.52-5.36-5.366.8358.770.09150.85921.57585,153.50-7.1925.41-8.3631.2663.2063.37-78.5332.866.05--0.08630.54-92.7211.81-120.45--2.43--
Jinyao Pharmaceutical Co Ltd3.66bn107.59m4.32bn2.68k40.131.43--1.180.09840.09843.352.760.57382.289.371,365,219.002.331.914.173.4042.6146.334.063.310.758427.180.206444.402.559.28230.60-4.22-9.589.21
Shanghai OPM Biosciences Co Ltd254.91m49.43m4.33bn285.0087.822.01--16.980.42940.42942.2218.800.10952.072.54894,431.902.094.342.164.6558.8658.3119.0623.4019.91--0.031545.38-17.4148.34-48.72--6.09--
Data as of May 31 2024. Currency figures normalised to Hunan Warrant Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

24.03%Per cent of shares held by top holders
HolderShares% Held
Ping An Fund Management Co., Ltd.as of 31 Dec 20231.14m5.70%
Essence Fund Co., Ltd.as of 31 Dec 2023907.86k4.55%
Harvest Fund Management Co., Ltd.as of 31 Dec 2023458.94k2.30%
Hwabao WP Fund Management Co., Ltd.as of 31 Dec 2023432.23k2.16%
China Universal Asset Management Co., Ltd.as of 31 Dec 2023402.09k2.01%
Penghua Fund Management Co., Ltd.as of 31 Dec 2023382.88k1.92%
CCB Principal Asset Management Co., Ltd.as of 31 Dec 2023351.00k1.76%
China Southern Asset Management Co., Ltd.as of 30 Jun 2023302.87k1.52%
Baoying Fund Management Co., Ltd.as of 31 Dec 2023251.13k1.26%
China Asset Management Co., Ltd.as of 31 Dec 2023171.18k0.86%
More ▼
Data from 31 Dec 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.